Loading clinical trials...
Loading clinical trials...
Exercise and Inflammation: Autonomic, Affective & Cellular Mechanisms
The purpose of this study is to test the hypothesis that aerobic exercise leads to attenuation of the inflammatory response to lipopolysaccharide (LPS) stimulation.
Aerobic exercise - the most widely recommended health behavior - is recognized to reduce the risk of coronary heart disease, so much so that consensus panels routinely include it as part of a cardioprotective regimen for healthy people, but the physiological or mechanistic basis of this protection is uncertain. Understanding the mechanisms has considerable public health significance because it will allow development and testing of targeted interventions to produce comparable cardioprotective effects more directly or in cases where aerobic exercise is not possible. This application proposes to test the hypothesis that aerobic training leads to attenuation of the inflammatory response to LPS stimulation and to examine the role played by exercise-induced increases in vagal activity, improvements in mood, and decreased expression of Toll Receptor 4 (TLR4), the cognate receptor for endotoxin expressed by monocytes.
Age
20 - 45 years
Sex
ALL
Healthy Volunteers
Yes
Columbia University Medical Center
New York, New York, United States
Start Date
January 1, 2010
Primary Completion Date
April 1, 2015
Completion Date
April 1, 2015
Last Updated
June 11, 2018
241
ACTUAL participants
aerobic training
BEHAVIORAL
Wait list
BEHAVIORAL
Lead Sponsor
New York State Psychiatric Institute
Collaborators
NCT07241390
NCT03372733
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06909773